Investigation Overview
January 13, 2017 (Shareholders Foundation) - An investigation on behalf of investors of Anthera Pharmaceuticals Inc (NASDAQ:ANTH) shares over potential securities laws violations by Anthera Pharmaceuticals and certain of its directors and officers in connection certain financial statements was announced. The investigation by a law firm focuses on possible claims on behalf of purchase...
You must register (for free) or login to view the entire investigation.